Sutton Wealth Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,074
| Closed | -$197K | – | 1359 |
|
|
2021
Q2 | $197K | Hold |
1,074
| – | – | 0.07% | 178 |
|
|
2021
Q1 | $164K | Buy |
1,074
+5
| +0.5% | +$773 | 0.06% | 187 |
|
|
2020
Q4 | $167K | Buy |
1,069
+18
| +2% | +$2.31K | 0.07% | 177 |
|
|
2020
Q3 | $120K | Hold |
1,051
| – | – | 0.06% | 196 |
|
|
2020
Q2 | $118K | Sell |
1,051
-70
| -6% | -$7.43K | 0.06% | 196 |
|
|
2020
Q1 | $101K | Hold |
1,121
| – | – | 0.06% | 192 |
|
|
2019
Q4 | $121K | Hold |
1,121
| – | – | 0.06% | 197 |
|
|
2019
Q3 | $110K | Sell |
1,121
-4
| -0.4% | -$451 | 0.06% | 197 |
|
|
2019
Q2 | $147K | Sell |
1,125
-7
| -0.6% | -$902 | 0.08% | 171 |
|
|
2019
Q1 | $153K | Buy |
1,132
+8
| +0.7% | +$995 | 0.09% | 164 |
|
|
2018
Q4 | $109K | Buy |
1,124
+73
| +7% | +$8.63K | 0.07% | 183 |
|
|
2018
Q3 | $146K | Sell |
1,051
-2
| -0.2% | -$251 | 0.1% | 157 |
|
|
2018
Q2 | $131K | Sell |
1,053
-8
| -0.8% | -$935 | 0.09% | 171 |
|
|
2018
Q1 | $118K | Buy |
1,061
+5
| +0.5% | +$598 | 0.08% | 180 |
|
|
2017
Q4 | $126K | Sell |
1,056
-11
| -1% | -$1.34K | 0.09% | 175 |
|
|
2017
Q3 | $150K | Hold |
1,067
| – | – | 0.11% | 153 |
|
|
2017
Q2 | $130K | Buy |
1,067
+5
| +0.5% | +$582 | 0.1% | 172 |
|
|
2017
Q1 | $129K | Sell |
1,062
-5
| -0.5% | -$645 | 0.11% | 158 |
|
|
2016
Q4 | $131K | Buy |
1,067
+11
| +1% | +$1.35K | 0.12% | 152 |
|
|
2016
Q3 | $129K | Buy |
1,056
+5
| +0.5% | +$644 | 0.12% | 150 |
|
|
2016
Q2 | $123K | Buy |
1,051
+3
| +0.3% | +$426 | 0.12% | 152 |
|
|
2016
Q1 | $146K | Buy |
+1,048
| New | +$154K | 0.14% | 130 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM